PINS Stimulator System for Deep Brain Stimulation of the Nucleus Accumbens to Treat Severe Opioid Addiction
Early Phase 1
- Conditions
- Opioid Addiction
- Interventions
- Device: Deep brain stimulation:PINS Stimulation System
- Registration Number
- NCT02282072
- Lead Sponsor
- Beijing Pins Medical Co., Ltd
- Brief Summary
The purpose of this study is to verify efficacy and safety of a bilateral deep brain stimulation (DBS) of the Nucleus accumbens (NAc) as a treatment option for severe opioid addiction.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- Age > 18 years old.
- In accordance with the diagnostic standards of DSM-IV & ICD-10 for addicted and DSM-IV for abstinence.
- Qualitative urine detection for opioids showing positive result.
- Cleared for 8 to 36 hours after their last drug taking.
- Fully understood and signed on informed consent.
Exclusion Criteria
- Person with consciousness disorder on opioid abstinence, seriously aggressive, heavily dehydrated and intending to commit suicide.
- Patients with serious liver and kidney dysfunction, pulmonary decompensation, or complicated with serious damage in other systems.
- Patients with serious infectious disease.
- Patients with history of serious neurological or psychiatrical diseases.
- Person with history of HIV infection or serious malnutrition.
- Dependent upon and addicted to multiple drugs.
- Attended some other drug trials within one month.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Deep Brain Stimulation Deep brain stimulation:PINS Stimulation System Stimulator is ON Placebo Deep brain stimulation:PINS Stimulation System Stimulator is OFF
- Primary Outcome Measures
Name Time Method Schedule for the Assessment of Negative Symptoms (SANS) 6 month
- Secondary Outcome Measures
Name Time Method Chronic Hunger Scale 6 month Beck Depression Inventory 6 month Buss & Perry Aggression Questionnaire 6 month
Trial Locations
- Locations (1)
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
🇨🇳Shanghai, Shanghai, China